Clinicians

Find out how REMs can help your patients

Canadian leader in mobile BMD scans utilizing safe, state-of-the-art R.E.M.S. technology

  • Self Referral
  • No Ionizing Radiation
  • Unlimited visits
DXA vs REMS

REMs TECHNOLOGY VS DXA

Vertebrae

Joint

DXA
PARAMETER
REMS
0.040-0.047 g/cm2
Smallest Detectable Difference (SDD)
0.009 g/cm2
1.78-2.02%
Intra-operator Repeatability
0.38%
4.93-5.60%
Least Significant Change (LSC, %)
1.05%
n.d.
Inter-operator Repeatibility
0.54%
Study

Medical Studies

REMS vs DXA EU Multicenter Clinical Study- Bone 2020

Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context

Florence, Italy

20 minute read

Fragility Score Study

Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study

LE, Italy

30 minute read

DXA Errors

Prevalence and type of errors in dual-energy x-ray absorptiometry

European Society of Radiology

15 minute read

Degennaro et al. - First assessment of bone mineral density in healthy pregnant women by means of Radiofrequency Echographic Multi Spectrometry (REMS) technology

First assessment of bone mineral density in healthy pregnant women by means of Radiofrequency Echographic Multi Spectrometry (REMS) technology

European Society of Radiology

15 minute read

Radiofrequency echographic multi‑spectrometry

Radiofrequency echographic multi‐spectrometry for the in‐vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

European Society of Radiology

15 minute read

RFEM identifies osteoporosis

Ability of radiofrequency echographic multispectrometry to identify osteoporosis status in elderly women with type 2 diabetes

Aging Clinical and Experimental Research

15 minute read

Comparing REMS to DXA: Osteoporosis Evaluation

New technology REMS for bone evaluation compared to DXA in adult women for the osteoporosis diagnosis: a real-life experience

International Osteoporosis Foundation and National Osteoporosis Foundation

15 minute read

HOW IT WORKS

REMs Technical Information

EchoLight technology is the best non-OHIP option when it comes to your bone health.

1

Self Referral

Since the cost of the service is not covered by any provincial health plan there is no requirement for medical professional referral. We welcome medical referrals but they are not necessary so the patient may refer themselves.

2

In Clinic or On-The-Go

Unlike DXA, the REMS technology is designed to be fully mobile if required. Therefore the offering of the service can be more versatile as it can be offered from a clinic setting or travel to the patient if required i.e. seniors home.

3

More comprehensive study

REMS addresses many of the shortcomings of DXA:

• calculates a more accurate level of bone density,

• is more sensitive to change in bone density so can assess treatment programs more frequently.

DXA requires a change of 5-6% in bone density whereas REMS can detect changes of 0.5-1% or 400-900% increase in sensitivity. DXA requires about 2 yrs to see a difference whereas REMS can see change in 3-6 months.

4

Non-ionizing radiation

DXA utilizes x-rays to assess bone health, REMS utilizes ultrasound to assess bone health so is safe for everyone.

5

Gives more info than Dexa

REMS not only assess the density of bone but also assess the microarchitecture of the bone to assess the quality of the bone. This assessment is expressed numerically in a fragility index. This value is combined with the calculated density score to produce a 5 year risk factor of fracture.

6

Immediate Reporting

REMS utilizes a database of over 100,000 patients to perform required calculations for the bone density score. The analysis of the received information concerning the microarchitecture is also done immediately. This allows the system to produce a complete report in less than 2 minutes following the conclusion of the exams (80 second scan for the spine and 40 seconds scan for the hip).

Echolight Resources

Who is a good fit for Echolight?

Top Echolight resources to share with your patients.

Echolight

Feel Confident Promoting Echolight to your Patients

Outcome driven numbers backed by happy, healthy patients.

1

Global Use

Multiple countries in the EU, Japan, Brazil, Australia, USA and Canada are leading the world in the use of REMS

2

Preferred Method

Italy has recently declared REMS as the preferred method for assessing bone health

3

World Congress

REMS technology was featured in a major symposium on fragility fracture prevention at the World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases May 4-7 2023.

4

EU Approved

REMS had been recently approved for the clinical use by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Scientific Community

Prestigious personalities of the world scientific community have chosen REMS technology

medical

Prof. Jean-Yves Reginster
ESCEO President
Head of the bone andcartilage, Metabolism Unit.University of LiegiLiegi, Belgium.

medical

Prof. Cyrus Cooper
IOF President
Professor of RheumatologyUniversity of SouthamptonSouthampton General HospitalUnited Kingdom

medical

Prof. Maria Luisa Brandi
Director of Bone Mineral andMetabolism diseases Unit
Careggi Hospital in Florence.Prof. of Endocrinology Univeristy of Florence.

medical

Prof. Adolfo Diez-Perez
Department ofInternal Medicine.
Hospital del MarBarcelona University Barcelona, Spain

medical

Dr Ludovica Borsoi
Centre for Research on Health and social Care Management
As regards the vertebral site, compared to DXA there was observed a greater ability to identify true positives and similar ability to identify true negatives

medical

Prof. René Rizzoli
Emeritus Professor of Medicine
University Hospitals andFaculty of Medicine.Geneva UniversitySwitzerland

medical

Prof. Bernard Cortet
President of the GRIOScientific Board of Paris
Professor in RheumatologyRoger Salengro HospitalChu de Lille, France.

Learn More

Get in touch

Find out how you can get more information or book in-person information sessions

I'm looking for: